Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 178340, 6 pages
http://dx.doi.org/10.1155/2012/178340
Clinical Study

The Expression of Selected Proapoptotic Molecules in Dermatitis Herpetiformis

1Department of Dermatology and Venereology, Medical University of Lodz, Krzemieniecka Street no. 5, 94-017 Lodz, Poland
2Laboratory of Nephropathology, Medical University of Lodz, Pomorska street no. 251, 92-216 Lodz, Poland

Received 14 January 2012; Revised 6 April 2012; Accepted 25 April 2012

Academic Editor: Takashi Hashimoto

Copyright © 2012 Zebrowska Agnieszka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Caproni, E. Antiga, L. Melani, P. Fabbri, and Italian Group for Cutaneous Immunopathology, “Guidelines for the diagnosis and treatment of dermatitis herpetiformis,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 6, pp. 633–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. L. Reunala, “Dermatitis herpetiformis,” Clinics in Dermatology, vol. 19, no. 6, pp. 728–736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Edinger and C. B. Thompson, “Death by design: apoptosis, necrosis and autophagy,” Current Opinion in Cell Biology, vol. 16, no. 6, pp. 663–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Teraki and T. Shiohara, “Apoptosis and the skin,” European Journal of Dermatology, vol. 9, no. 5, pp. 413–426, 1999. View at Google Scholar · View at Scopus
  5. Z. M. Kiliańska and A. Miśkiewicz, “Kaspazy kręgowców; ich rola w przebiegu apoptozy,” Posępyt Bioogii Komórki, vol. 30, pp. 129–152, 2003. View at Google Scholar
  6. J. C. Reed, “Mechanisms of apoptosis,” The American Journal of Pathology, vol. 157, no. 5, pp. 1415–1430, 2000. View at Google Scholar · View at Scopus
  7. I. Grądzka, “Apoptoza: decyzja należy do mitochondrium,” Postępy Biochemii, vol. 46, no. 1, pp. 2–16, 2000. View at Google Scholar
  8. P. Wehrli, I. Viard, R. Bullani, J. Tschopp, and L. E. French, “Death receptors in cutaneous biology and disease,” Journal of Investigative Dermatology, vol. 115, no. 2, pp. 141–148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. L. E. French and J. Tschopp, “Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover,” Behring Institute Mitteilungen, no. 97, pp. 156–160, 1996. View at Google Scholar · View at Scopus
  10. D. Sulejczak, “Apoptoza i metody jej identyfikacji,” Postępy Biologii Komórki, vol. 27, pp. 527–568, 2000. View at Google Scholar
  11. Z. Darzynkiewicz, G. Juan, X. Li, W. Gorczyca, T. Murakami, and F. Traganos, “Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis),” Cytometry, vol. 27, no. 1, pp. 1–20, 1997. View at Publisher · View at Google Scholar
  12. I. Viard, P. Wehrli, R. Bullani et al., “Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin,” Science, vol. 282, no. 5388, pp. 490–493, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Vassina, M. Leverkus, S. Yousefi, L. R. Braathen, H. U. Simon, and D. Simon, “Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis,” Journal of Investigative Dermatology, vol. 125, no. 4, pp. 746–752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Mikalowski, “Microscopic electronique de l'epiderme dans les bulles de la dermatite herpetiforme de Dühring-Brocq,” Annales Dermatology Syphilology, vol. 91, article 255, 1964. View at Google Scholar
  15. M. Caproni, D. Torchia, E. Antiga et al., “The role of apoptosis in the pathogenesis of dermatitis herpetiformis,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 4, pp. 691–699, 2005. View at Google Scholar · View at Scopus
  16. H. Tomková, W. Fujimoto, and J. Arata, “Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers,” European Journal of Dermatology, vol. 8, no. 4, pp. 256–260, 1998. View at Google Scholar · View at Scopus
  17. I. Viard-Leveugle, R. R. Bullani, P. Meda et al., “Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 16183–16188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Oishi, K. Maed'a, and S. Sugiyama, “Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines,” Archives of Dermatological Research, vol. 286, no. 7, pp. 396–407, 1994. View at Google Scholar · View at Scopus
  19. S. H. Lee, J. J. Jang, J. Y. Lee et al., “Fas ligand is expressed in normal skin and in some cutaneous malignancies,” British Journal of Dermatology, vol. 139, no. 2, pp. 186–191, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Morawej, M. Yousefi, B. Farrokhi, and N. Mosaffa, “Soluble Fas in pemphigus vulgaris,” Archives of Iranian Medicine, vol. 14, no. 3, pp. 200–201, 2011. View at Google Scholar · View at Scopus
  21. A. Erkiert-Polguj, A. Żebrowska, M. Wągrowska-Danilewicz, M. Danilewicz, A. Nykiel, and E. Waszczykowska, “Expression of selected pro-apoptotic proteins in pemphigoid,” Advances in Dermatology and Allergology, vol. 27, no. 1, pp. 6–14, 2011. View at Google Scholar · View at Scopus
  22. M. Irmler, M. Thome, M. Hahne et al., “Inhibition of death receptor signals by cellular FLIP,” Nature, vol. 388, no. 6638, pp. 190–195, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Glass, C. M. Walsh, D. H. Lynch, and W. R. Clark, “Regulation of the Fas lytic pathway in cloned CTL,” The Journal of Immunology, vol. 156, no. 10, pp. 3638–3644, 1996. View at Google Scholar · View at Scopus
  24. S. M. Farley, A. D. Dotson, D. E. Purdy et al., “Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis,” Journal of Investigative Dermatology, vol. 126, no. 11, pp. 2438–2451, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Wajant, K. Pfizenmaier, and P. Scheurich, “Non-apoptotic Fas signaling,” Cytokine and Growth Factor Reviews, vol. 14, no. 1, pp. 53–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Graeber, B. S. Baker, J. J. Garioch, H. Valdimarsson, J. N. Leonard, and L. Fry, “The role of cytokines in the generation of skin lesions in dermatitis herpetiformis,” British Journal of Dermatology, vol. 129, no. 5, pp. 530–532, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Caproni, C. Feliciani, A. Fuligni et al., “Th2-like cytokine activity in dermatitis herpetiformis,” British Journal of Dermatology, vol. 138, no. 2, pp. 242–247, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Zebrowska, A. Erkiert-Polguj, M. Wągrowska-Danilewicz et al., “Eotaxin (CCL11), TARC [thymus and activation-regulated chemokine (CCL17)], MCP-1 (CCL2) and CCR-1, CXCR-1, CXCR-2 expression in dermatitis herpetiformis and bullous pemphigoid,” Archives of Medical Science, vol. 5, no. 3, pp. 475–485, 2009. View at Google Scholar · View at Scopus
  29. S. M. Frisch and H. Francis, “Disruption of epithelial cell-matrix interactions induces apoptosis,” Journal of Cell Biology, vol. 124, no. 4, pp. 619–626, 1994. View at Google Scholar · View at Scopus
  30. Y. Pan, R. Xu, M. Peach et al., “Evaluation of pharmacodynamic biomarkers in a phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours,” British Journal of Cancer, vol. 105, no. 12, pp. 1830–1838, 2011. View at Google Scholar
  31. J. P. Sheridan, S. A. Marsters, R. M. Pitti et al., “Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors,” Science, vol. 277, no. 5327, pp. 818–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Leverkus, M. R. Sprick, T. Wachter et al., “TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2,” Journal of Investigative Dermatology, vol. 121, no. 1, pp. 149–155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. G. De Panfilis, D. Semenza, A. Lavazza, A. A. Mulder, A. M. Mommaas, and G. Pasolini, “Keratinocytes constitutively express the CD95 ligand molecule on the plasma membrane: an in situ immunoelectron microscopy study on ultracryosections of normal human skin,” British Journal of Dermatology, vol. 147, no. 1, pp. 7–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. H. Li, N. C. Kirkiles-Smith, J. M. McNiff, and J. S. Pober, “Trail induces apoptosis and inflammatory gene expression in human endothelial cells,” The Journal of Immunology, vol. 171, no. 3, pp. 1526–1533, 2003. View at Google Scholar · View at Scopus
  35. A. Zebrowska, E. Waszczykowska, M. Wągrowska-Danilewicz et al., “Expression of selected adhesion molecules in dermatitis herpetiformis and bullous pemphigoid,” Polish Journal of Pathology, vol. 60, no. 1, pp. 26–34, 2009. View at Google Scholar · View at Scopus
  36. S. A. Renshaw, J. S. Parmar, V. Singleton et al., “Acceleration of human neutrophil apoptosis by TRAIL,” The Journal of Immunology, vol. 170, no. 2, pp. 1027–1033, 2003. View at Google Scholar · View at Scopus
  37. N. L. Wu, T. A. Lee, T. L. Tsai, and W. W. Lin, “TRAIL-induced keratinocyte differentiation requires caspase activation and p63 expression,” Journal of Investigative Dermatology, vol. 131, no. 4, pp. 874–883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Suliman, A. Lam, R. Datta, and R. K. Srivastava, “Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways,” Oncogene, vol. 20, no. 17, pp. 2122–2133, 2001. View at Publisher · View at Google Scholar · View at Scopus